The Role Of Bisphenol A In The Development Of Chronic Disease
Funder
National Health and Medical Research Council
Funding Amount
$397,549.00
Summary
There is accumulating evidence to suggest that the environment we live in may be important in the development of chronic disease. This project examines a key environmental toxin Bisphenol A (BPA) and explores the role it has in the development of diabetes, obesity and cardiovascular disease (CVD). In this project, we will explore whether there is an independent relationship between BPA and the development of diabetes, CVD and obesity in humans in a prospective setting.
An Individual-level Study Of Suicide Method Substitution Over Time
Funder
National Health and Medical Research Council
Funding Amount
$218,122.00
Summary
This study will explore patterns of suicide methods _ e.g., whether people who attempt suicide by hanging make subsequent attempts in the following month, and, if so, whether they use the same or different methods. It will track anonymised patients who have been hospitalised for a suicide attempt in 3 Australian states to determine the extent, method and outcome of any subsequent attempts. The study will inform questions about ïbest betsÍ in terms of restricting access to means of suicide.
IMPROVE - Investigating Medication Re-Purposing To Reduce Risk Of OVarian Cancer And Extend Survival
Funder
National Health and Medical Research Council
Funding Amount
$430,196.00
Summary
Ovarian cancer is the 6th most common cause of cancer death in women and the proportion of women who die from their disease has not improved substantially over time. This large-scale study will use de-identified data from the Pharmaceutical Benefits Scheme, the Australian Cancer Database and the National Death Index to investigate whether medications commonly used for other conditions can help decrease the risk of ovarian cancer developing or improve survival from ovarian cancer after diagnosis.
Modelling The Possible Effects Of Low-dose Irradiation In Young Australians Exposed To CT Scans
Funder
National Health and Medical Research Council
Funding Amount
$130,877.00
Summary
Radiation from CT (computerised tomographic X-ray) scans of children may cause a later increase in cancer risk. However, any risk for an individual will be small, so we are using de-identified records to study the average risk of cancer in 600,000 young Australians exposed to CT scans between 1985-2005. Our project has the capacity to detect an increase of 10% in the risk of exposed compared with non-exposed. Results will be available by Dec 2012.
Prevention Of Multi-drug Resistant Tuberculosis In A High Prevalence Setting: ‘Connecting The DOTS’ In Vietnam
Funder
National Health and Medical Research Council
Funding Amount
$3,382,020.00
Summary
The close contacts of people with multi-drug resistant tuberculosis (MDR-TB) have a high risk of developing the disease. The V-QUIN MDR-TB Trial will evaluate the effectiveness of an oral antibiotic (levofloxacin) in preventing drug resistant TB among infected household contacts of TB patients. Household contacts from 10 Provinces in Vietnam will be randomly allocated to receive six-months of either levofloxacin or a placebo, and then followed for two years to see if they develop tuberculosis.
DNA Methylation As A Risk Factor For Colorectal Cancer
Funder
National Health and Medical Research Council
Funding Amount
$780,185.00
Summary
Methylation of DNA involves a change to the chemical composition of DNA. It can affect the function of genes and normal methylation is essential for life. Aberrant methylation is associated with many diseases, including colorectal cancer. In this grant, we will explore whether aberrant methylation of DNA obtained from the blood can predict the risk of colorectal cancer. Our ultimate aim is to better identify people at higher risk of cancer.
Improving Skin Cancer Prevention: Motivating Preventive Behaviours Using Knowledge Of Personalised Genomic Risk Of Melanoma
Funder
National Health and Medical Research Council
Funding Amount
$1,041,720.00
Summary
The aim of our study is to evaluate whether we can improve the Australian public’s skin cancer prevention behaviours, particularly reducing exposure to ultraviolet (UV) radiation, by giving personalised information about melanoma genetic risk. We will also explore the psycho-social, ethical, and economic implications of receiving this information. The results of our study are likely to influence the future of skin cancer prevention in Australia.
Risk Factors For Food Allergy And The Allergic March To Asthma In Childhood: The HealthNuts Study
Funder
National Health and Medical Research Council
Funding Amount
$1,876,796.00
Summary
Food allergy appears to represent a second epidemic of allergic disease. It is not known why some children grow out of their food allergy or how food allergy in the first year of life impacts asthma and allergy in later childhood. HealthNuts is a large study of 5300 children that can answer these questions. HealthNuts visited children at ages 1, 4 and 6 and requests funding to re-visit them at age 10. Results will help prevent children developing food allergy, asthma and the allergic march.
HIV Treatment As Prevention: A Longitudinal Assessment Of Population Effectiveness
Funder
National Health and Medical Research Council
Funding Amount
$783,160.00
Summary
This project is a large-scale evaluation of an HIV strategy known as ‘treatment as prevention’ (TasP). Through routine and repeat HIV testing for gay men and early treatment initiation following diagnosis, TasP aims to reduce HIV community infection rates. Through the establishment of a large cohort of gay men in NSW and Victoria, this study will track HIV testing, treatment and management to assess the real-world efficacy of TasP for reducing HIV infections among this at-risk population.
Early Introduction Of Dietary Allergen To Reduce The Population Prevalence Of Infant Food Allergy
Funder
National Health and Medical Research Council
Funding Amount
$412,468.00
Summary
Australia has the highest recorded prevalence of childhood peanut allergy, a potentially life-threatening condition. New evidence shows introducing peanut into the diet in infancy can reduce the risk of developing peanut allergy in high risk infants, and allergy prevention guidelines now recommend giving peanut before 12 months. This study will evaluate how effective these guidelines have been in promoting earlier peanut introduction and reducing the population prevalence of peanut allergy.